Treatment with oral biphosphonates can increase the sensitivity of sestamibi radionuclide imaging in patients with primary hyperparathyroidism

International Journal of Clinical Pharmacology Research

Volumn 25, Issue 1, 2005, Pages 19-28

  Makras, P ^a   Kaltsas, G A ^a   Athanasoulis, T ^b   Papadogias, D ^a   Zografos, G N ^a   Kontogeorgos, G ^a   Borboli, N ^a   Piaditis, G ^a  

^a G GENNIMATAS GENERAL HOSPITAL   (Greece)

^b ALEXANDRA HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOISOTOPE;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DRUG POTENTIATION; FEMALE; HUMAN; MALE; PARATHYROID ADENOMA; PARATHYROID DISEASE; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HYPERPLASIA; PARATHYROIDECTOMY; PHOSPHATE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; SENSITIVITY AND SPECIFICITY;

ADENOMA; AGED; ALENDRONATE; CALCIUM; FEMALE; HUMANS; HYPERPARATHYROIDISM; HYPERPLASIA; MALE; MIDDLE AGED; PARATHYROID GLANDS; PARATHYROID HORMONE; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; PHOSPHATES; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TECHNETIUM TC 99M SESTAMIBI;

EID: 17644371652     PISSN: 02511649     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Johnston L.B., Carroll M.J., Britton K.E., et al. The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging. J. Clin. Endocrinol. Metabol., 81, 346, 1996.
2. O'Doherty M.J. Radionuclide parathyroid imaging. J. Nucl. Med., 38, 840, 1997.
3. O'Doherty M.J., Kettle A.G. Parathyroid imaging: Preoperative localization. Nucl. Med. Commun., 24, 125, 2003.
4. Thomas S.K., Wishart G.C. Trends in surgical techniques. Nucl. Med. Commun., 24, 115, 2003.
5. Royal R.E., Delpassand E.S., Shapiro S.E., et al. Improving the yield of preoperative parathyroid localization: Technetium Tc 99m-sestamibi imaging after thyroid suppression. Surgery, 132, 968, 2002.
6. Sebag F., Hubbard J.G., Maweja S., Misso C., Tardivet L., Henry J.F. Negative preoperative localization studies are highly predictive of multiglandular disease in sporadic primary hyperparathyroidism. Surgery, 134, 1038, 2003.
7. Lorberboym M., Ami D.B., Zin D., Nikolov G., Adar E. Incremental diagnostic value of 99mTc methylene diphosphonate bone SPECT in patients with patellofemoral pain disorders. Nucl. Med. Commun., 24, 403, 2003.
8. Carpentier A., Jeannotte S., Verreault J., et al. Preoperative localization of parathyroid lesions in hyperparathyroidism: Relationship between technetium-99m-MIBI uptake and oxyphil cell content. J. Nucl. Med., 39, 1441, 1998.
9. Pons F., Torregrosa J.V., Fuster D. Biological factors influencing parathyroid localization. Nucl. Med. Commun., 24, 121, 2003.
10. Chen H., Mack E., Starling J.R. Radioguided parathyroidectomy is equally effective for both adenomatous and hyperplastic glands. Ann. Surg., 238, 332, 2003.
11. Toft A.D. Surgery for primary hyperparathyroidism - sooner rather than later. Lancet, 355, 1478, 2000.
12. Rubello D., Casara D., Pelizzo M.R. Optimization of preoperative procedures. Nucl. Med. Commun., 24, 133, 2003.
13. Denham D.W., Norman J. Cost-effectiveness of preoperative sestamibi scan for primary hyperparathyroidism is dependent solely upon the surgeon's choice of operative procedure. J. Am. Coll. Surg., 186, 293, 1998.
14. Adami S., Mian M., Bertoldo F., et al. Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: Effects of bisphosphonate treatment. Clin. Endocrinol. (Oxf), 33, 391, 1990.
15. Daokiw A.P., Sussman J.J., Pritsche H.A. Jr., et al. Relative contributions of technetium Tc 99m sestamibi scintigraphy, intraoperative gamma probe detection, and the rapid parathyroid hormone assay to the surgical management of hyperparathyroidism. Arch. Surg., 135, 550, 2000.
16. Bilezikian J.P., Potts J.T. Jr, Fuleihan G., et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: A perspective for the 21st century. J. Clin. Endocrinol. Metabol., 87, 5353, 2002.
17. Moka D., Voth E., Dietlein M., Larena-Avellaneda A., Schicha H. Technetium 99m-MIBI-SPECT: A highly sensitive diagnostic tool for localization of parathyroid adenomas. Surgery, 128, 29, 2000.
18. Katz S.C., Wang G.J., Kramer E.L., Roses D.F. Limitations of technetium 99m sestamibi scintigraphic localization for primary hyperparathyroidism associated with multiglandular disease. Am. Surg., 69, 170, 2003.
19. Parikshak M., Pawlak S.E., Eggenberger J.C., Lee C.S., Szilagy E.J., Margolin D.A. The role of endoscopic colon surveillance in the transplant population. Dis. Colon. Rectum, 45, 1655, 2002.
20. Haciyanli M., Lal G., Morita E., Duh Q.Y., Kebebew E., Clark O.H. Accuracy of preoperative localization studies and intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma. J. Am. Coll. Surg., 197, 739, 2003.
21. Norman J., Denham D. Minimally invasive radioguided parathyroidectomy in the reoperative neck. Surgery, 124, 1088, 1998.
22. Feingold D.L., Alexander H.R., Chen C.C., et al. Ultrasound and sestamibi scan as the only preoperative imaging tests in reoperation for parathyroid adenomas. Surgery, 128, 1103, 2000.
23. Ariel C., Cheah W.K., Ituarte P.H., et al. Can localization studies be used to direct focused parathyroid operations? Surgery, 129, 720, 2001.
24. Perrier N.D., Ituarte P.H., Morita E., et al. Parathyroid surgery: Separating promise from reality. J. Clin. Endocrinol. Metab., 87, 1024, 2000.
25. Nielsen S.L. Improvement of parathyroid scintigraphy by gland stimulation [abstract]. Eur. J. Nucl. Med. Mol. Imaging, 31(Suppl. 2), S429, 2004.
26. Rubello D., Casara D., Pelizzo M.R. Is thyroid suppression an effective procedure in improving preoperative sestamibi parathyroid scintigraphy? Surgery, 135, 462, 2004.
27. Kao A., Shiau Y.C., Tsai S.C., Wang J.J., Ho S.T. Technetium-99m methoxyisobutylisonitrile imaging for parathyroid adenoma: Relationship to P-glycoprotein or multidrug resistance-related protein expression. Eur. J. Nucl. Med. Mol. Imaging, 29, 1012, 2002.